Novartis Bioventures Ltd Insider Trading $AKBA Akebia Therapeutics, Inc.
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 3,405,764 shares
Current Value: $33,648,948
Latest Transaction: Mar 27 2014
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in Akebia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 708,647 | 0 | 0 | |
| Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 347,831 | 0 | 0 | |
| Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 257,031 | 0 | 0 | |
| Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 3,223,174 | 0 | 3,405,764 | 182.6 K to 3.4 M (+1,765.25 %) |
| Mar 27 2014 | AKBA | Akebia Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 17.00 | 182,590 | 3,104,030 | 182,590 | 0 to 182.6 K |
Page: 1